Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × omipalisib × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3 Dermatologic 2 CNS 2 Thoracic 1 Other hematologic neoplasm 1 Lymphoid 1

Conditions

Interventions

Rituximab 1173 Cyclophosphamide 1111 Vincristine 559 Doxorubicin 499 Etoposide 451 Prednisone 426 Cytarabine 408 fludarabine 401 Methotrexate 363 Dexamethasone 342 fludarabine phosphate 332 Lenalidomide 302 Filgrastim 298 Bendamustine Hydrochloride 235 Radiotherapy 231 venetoclax 220 ibrutinib 208 obinutuzumab 195 Melphalan 194 Peripheral Blood Stem Cell Transplantation 190 Granulocyte Colony-Stimulating Factor 174 Gemcitabine 171 Bortezomib 167 Busulfan 157 Whole-Body Irradiation 156 Mycophenolic Acid 144 Tacrolimus 124 Specimen Handling 122 Ifosfamide 122 Calcium Dobesilate 122

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00972686 2017-05-09

FTIH

GlaxoSmithKline

Phase 1 Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡